Novavax and its partner the Serum Institute say their request for the COVID-19 vaccine to the UN health agency is based on a previous submission to Indian regulators.
J&J has tied up with Hyderabad-based Biological E for the global supply chain network, hoping to supply its Covid-19 vaccine Janssen through extensive collaborations and partnerships.
For the national COVID vaccination programme, J&J’s single dose vaccine is slated as a crucial component as it may be logistically easy to administer and offers quick coverage to a vast population
Earlier, Novavax had said that its vaccine has an efficacy of 90.4% in preventing infection and 100% efficacy against moderate to severe disease.
NITI Aayog Member (Health) V K Paul said the data available in public domain also indicates the vaccine is safe and highly effective.
These results assume significance for India as Centre had earlier indicated that about 20 crore doses of the vaccine may be available in the country between August-December.
The DPA gives the US president powers to allocate materials, services, and facilities and award contracts that are prioritised over others to promote national defence.
Officials say SK Bioscience is contracted to manufacture 40 million doses of the Novavax vaccine this year.